Novartis to spin off Sandoz, list it in Zurich
Completion was expected in the second half of next year, the Swiss pharma group said.
Arndt Wiegmann | Reuters
Novartis said on Thursday it would spin off Sandoz and list it on the Swiss stock exchange to create the No.1 European generics company.
“For both the innovative medicines and Sandoz businesses, the spin-off would enable enhanced focus and the ability to pursue independent growth strategies,” the Swiss pharma group said in a statement.
Completion was expected in the second half of next year, he added.
.
Completion was expected in the second half of next year, the Swiss pharma group said. Arndt Wiegmann | Reuters Novartis said on Thursday it would spin off Sandoz and list it on the Swiss stock exchange to create the No.1 European generics company. “For both the innovative medicines and Sandoz businesses, the spin-off would enable…
Recent Posts
- Putin mercenary who ‘waved the skull of a dead Ukrainian’ days after he was shot in the head
- Naked woman, 52, kicked a police officer in the crotch after he tried to ‘cover her modesty’
- China’s economy to grow 5% in 2023, Fitch Ratings says in an upgraded forecast
- Newcastle: Radioactive device found in burnt out car at Merewether Golf Club, Adamstown
- Longboard Pharmaceuticals prices $20M offering